148sek
-0,7 %
Date:2025-06-26Time:17:24:38Latest report:Q1-2025List:Small CapTicker:ONCO
Market Cap:339 msekEnterprise Value:350 msekNet Sales:39,8 msekEarnings:-277,5 msekEmployees:0ISIN:SE0009414576

Ratios

10-year key figure history for Oncopeptides turnover, profit, dividend, equity, PE and PB.

Pre
Pre

Stockprice

Price movement for Oncopeptides with index and moving average MA50 and MA200.

Stockprice:1,48
MA50:1,78
MA200:1,73
Price/MA200:-13,4 %
RSI (14):35,6
Price/MA50:-15,7 %

Description

Oncopeptides is a biotech company that develops drugs for difficult-to-treat hematological diseases. The company uses its PDC platform to develop peptide-linked drugs that selectively deliver cytotoxic drugs into cancer cells. The company has drugs in commercialization and several drug candidates under development. Oncopeptide's head office is located in Stockholm.

Biotechnology